Harbert Discovery Fund Responds To Enzo Biochem, Inc.'s Recent Strategic Announcements; Says Believes Interested Acquirers, Others Would Be Willing To Pay Significant Premium To Enzo Biochem's Curre
Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Mar. 16, 2021: ENZ, OCG, NHIC, HEXO, TKAT
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Enzo Therapeutics Awarded U.S. Patent 10,945,971 'Sphingosine kinase type 1 inhibitors and uses thereof'
Enzo Biochem Stock Up 50% as CEO Steps Down; 2Q Revenue Rises
8 Stocks Moving In Monday's After-Hours Session
Press Release: Enzo Biochem Reports Second Quarter Fiscal 2021 Results; Company Provides Leadership and Corporate Updates
Enzo Biochem shares are trading higher after the company reported Q2 EPS and sales results were higher year over year.
Enzo Biochem Q2 EPS $0.05 Up From $(0.12) YoY, Sales $31.50M Up From $19.38M YoY
BRIEF-Enzo Announces Its Genflex™ Molecular Test Detects Current Covid-19 Variants